High-density lipoproteins during sepsis: from bench to bedside - Université de La Réunion Accéder directement au contenu
Article Dans Une Revue Critical Care Année : 2020

High-density lipoproteins during sepsis: from bench to bedside

Résumé

High-density lipoproteins (HDLs) represent a family of particle characterized by the presence of apolipoprotein A-I (apoA-I) and by their ability to transport cholesterol from peripheral tissues back to the liver conferring them a cardioprotective function. HDLs also display pleiotropic properties including antioxidant, anti-apoptotic, antithrombotic, anti-inflammatory, or anti-infectious functions. Clinical data demonstrate that HDL cholesterol levels decrease rapidly during sepsis and that these low levels are correlated with morbi-mortality. Experimental studies emphasized notable structural and functional modifications of HDL particles in inflammatory states, including sepsis. Finally, HDL infusion in animal models of sepsis improved survival and provided a global endothelial protective effect. These clinical and experimental studies reinforce the potential of HDL therapy in human sepsis. In this review, we will detail the different effects of HDLs that may be relevant under inflammatory conditions and the lipoprotein changes during sepsis and we will discuss the potentiality of HDL therapy in sepsis.
Fichier principal
Vignette du fichier
s13054-020-02860-3.pdf (773.65 Ko) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-03043637 , version 1 (07-12-2020)

Licence

Paternité

Identifiants

Citer

Sébastien Tanaka, David Couret, Alexy Tran-Dinh, Jacques Duranteau, Philippe Montravers, et al.. High-density lipoproteins during sepsis: from bench to bedside. Critical Care, 2020, 24, pp.134. ⟨10.1186/s13054-020-02860-3⟩. ⟨hal-03043637⟩
79 Consultations
80 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More